Ionis Pharmaceuticals, Inc. Inventory, Raw Materials, Net of Reserves
Ionis Pharmaceuticals, Inc. (IONS) had Inventory, Raw Materials, Net of Reserves of $9.07 million as of 2018-06-30, per its 10-Q filed 2018-08-07.
Discontinued › Notes
us-gaap:InventoryRawMaterialsNetOfReserves · last filed 2018-08-07
- 2018-06-30: Inventory, Raw Materials, Net of Reserves $9.07M.
- 2018-03-31: Inventory, Raw Materials, Net of Reserves $9.06M.
- 2017-12-31: Inventory, Raw Materials, Net of Reserves $9.98M.
- 2017-09-30: Inventory, Raw Materials, Net of Reserves $8.45M.
| Period end | Inventory, Raw Materials, Net of Reserves |
|---|---|
| 2018-06-30 | $9.07M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $9.06M 10-Q · filed 2018-05-07 |
| 2017-12-31 | $9.98M 10-Q · filed 2018-08-07 |
| 2017-09-30 | $8.45M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $6.50M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $6.80M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $7.49M 10-K · filed 2018-02-28 |
| 2016-09-30 | $9.32M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $7.67M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $6.52M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $6.90M 10-K · filed 2017-03-01 |
| 2015-09-30 | $6.58M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $6.78M 10-Q · filed 2015-08-05 |
| 2015-03-31 | $6.84M 10-Q · filed 2015-05-05 |
| 2014-12-31 | $6.29M 10-K · filed 2016-02-26 |
| 2014-09-30 | $7.08M 10-Q · filed 2014-11-07 |
| 2014-06-30 | $7.78M 10-Q · filed 2014-08-04 |
| 2014-03-31 | $7.54M 10-Q · filed 2014-05-06 |
| 2013-12-31 | $8.03M 10-K · filed 2015-03-02 |
| 2013-09-30 | $7.38M 10-Q · filed 2013-11-05 |
| 2013-06-30 | $8.31M 10-Q · filed 2013-08-06 |
| 2013-03-31 | $5.81M 10-Q · filed 2013-05-07 |
| 2012-12-31 | $6.12M 10-K · filed 2014-03-03 |
| 2012-09-30 | $6.74M 10-Q · filed 2012-11-06 |
| 2012-06-30 | $7.11M 10-Q · filed 2012-08-06 |
| 2012-03-31 | $4.87M 10-Q · filed 2012-05-09 |
| 2011-12-31 | $4.14M 10-K · filed 2013-02-28 |
| 2011-09-30 | $2.92M 10-Q · filed 2011-11-08 |
| 2011-06-30 | $2.25M 10-Q · filed 2011-08-08 |
| 2010-12-31 | $2.48M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |